Apogee Therapeutics, Inc. (APGE) Operating Margin
- Operating margin · 12 months: Value (m); Formula and calculation Operating income / revenue. Period ending 2026-06-30..
Operating margin
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Operating margin · 12 months | (m) | Operating income / revenue. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Operating income | -328.11M USD | Operating Income (Loss) |
| Revenue | (m) | |
| Cost of products and services | (m) | |
| Research and development | 240.74M USD | Research and Development Expense |
| Selling, general and administration | (m) |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Operating income (USD) | Revenue (USD) | Cost of products and services (USD) | Research and development (USD) | Selling, general and administration (USD) | Operating margin |
|---|---|---|---|---|---|---|
| 2026-06-30 | $-328.11M | (m) | (m) | $240.74M | (m) | (m) |
| 2026-03-31 | $-305.27M | (m) | (m) | $229.14M | (m) | (m) |
| 2025-12-31 | $-285.60M | (m) | (m) | $214.71M | (m) | (m) |
| 2025-09-30 | $-283.42M | (m) | (m) | $216.50M | (m) | (m) |
| 2025-06-30 | $-270.83M | (m) | (m) | $208.03M | (m) | (m) |
| 2025-03-31 | $-241.78M | (m) | (m) | $185.54M | (m) | (m) |
| 2024-12-31 | $-216.87M | (m) | (m) | $167.87M | (m) | (m) |
| 2024-09-30 | $-178.14M | (m) | (m) | $136.59M | (m) | (m) |
| 2024-06-30 | $-143.76M | (m) | (m) | $107.94M | (m) | (m) |
| 2024-03-31 | $-118.53M | (m) | (m) | $88.69M | (m) | (m) |
| 2023-12-31 | $-93.00M | (m) | (m) | $68.42M | (m) | (m) |
| 2023-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-03-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-12-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.